Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Good Girl Rx vs WellMedr

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #82Desk pick
Good Girl Rx

Good Girl Rx (Good Girl LLC) offers compounded semaglutide and tirzepatide in injectable, microdose, and oral dissolving tablet (ODT) formats.

Marked down on: The advertised rates require twelve months paid up front; billed month to month the same products are $184 and $244, roughly 2.3 times as much

FDAWarning letter issued to Good Girl LLC dba GoodGirlRX in February 2026. See the FDA warning-letter database.

vs
Dispatch #343
WellMedr

Both molecules, a real brand-name Ozempic and Zepbound lane and an eight-SKU microdose line — advertised from $59 a month, a floor the company's own banner ties to a twelve-month plan and bills every four weeks.

Marked down on: The microdose page headlines "ZERO Side Effects" over a subhead reading "Zero side effct for 70%+ of members" (their typo) — an unqualified claim for a compounded GLP-1, on a page carrying none of the thyroid or compounding warnings the pricing page does

Good Girl Rx takes this head-to-head with the higher Desk Score, 77/100 (C+) against 55/100 (C) for WellMedr. WellMedr still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Good Girl Rx

77/100

C+

Overall

WellMedr

55/100

C

Price transparency

78
44

State access

86
24

Molecule range

90
86

Onboarding speed

63
62

Support responsiveness

72
75

Licensing & trust

62
58

The spec sheet

FieldGood Girl RxWellMedr
Semaglutide$79/mo (microdose tier, 12-month plan, compounded)From $59/mo (a floor — the banner ties $59/mo to a 12-month plan; billed every 4 weeks)
Tirzepatide$139/mo (microdose tier, 12-month plan, compounded)From $99/mo (a floor, flat at every dose; billed every 4 weeks)
CoverageAll 50 statesNot disclosed
Brand-nameYesYes
Oral optionYesYes
Best forPatients seeking multiple compounded GLP-1 formats with pharmacy quality standards.Readers shopping the low-dose end who want the dispensing pharmacy and the treating clinicians named, and who will read the twelve-month lock behind the $59 before they start.
Desk Score77/100C+55/100C

The verdict

Desk pick — Good Girl Rx

Good Girl Rx takes this head-to-head with the higher Desk Score, 77/100 (C+) against 55/100 (C) for WellMedr. WellMedr still holds its ground where its strengths line up with yours.

Choose Good Girl Rx if…

Patients seeking multiple compounded GLP-1 formats with pharmacy quality standards.

$79/mo (microdose tier, 12-month plan, compounded) sema · $139/mo (microdose tier, 12-month plan, compounded) tirz · All 50 states

FDAWarning letter issued to Good Girl LLC dba GoodGirlRX in February 2026. See the FDA warning-letter database.

Choose WellMedr if…

Readers shopping the low-dose end who want the dispensing pharmacy and the treating clinicians named, and who will read the twelve-month lock behind the $59 before they start.

From $59/mo (a floor — the banner ties $59/mo to a 12-month plan; billed every 4 weeks) sema · From $99/mo (a floor, flat at every dose; billed every 4 weeks) tirz · Not disclosed

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Good Girl Rx · WellMedr.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.